Found 340 matching trials
A Study on the Safety and Immunogenicity of Combined Intradermal and Intravenous Administration of an Autologous mRNA Electroporated Dendritic Cell Vaccine in Patients With Previously Treated Unresectable Stage III or IV Melanoma PHASE1 This phase I study plan is divided in the following four phases:
* Eligibi...
Show More Learn More & Join Trial
Vaccine Therapy in Treating Patients With Malignant Glioma PHASE1 RATIONALE: Vaccines made from a person's white blood cells mixed with tumor...
Show More Location
Jonsson Comprehensive Cancer Center at UCLA
Learn More & Join Trial
Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic Cancer PHASE2 RATIONALE: Gene-modified lymphocytes may stimulate the immune system in dif...
Show More Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Learn More & Join Trial
DC/NK Cell Therapy PHASE2 Primary Outcomes The primary objective of this trial is to test the safety ...
Show More Location
National Taiwan University Hospital Yunlin Branch
Learn More & Join Trial
PEP-DC and OC-DC Vaccine in High Grade Serous Ovarian Carcinoma PHASE1 Single center, phase I/II randomized 2-arm study, evaluating two different ...
Show More Location
Multiple Locations
Learn More & Join Trial
PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy PHASE1 A Phase I open-label, multicenter study, to evaluate the safety, feasibilit...
Show More Location
University of Florida
Learn More & Join Trial
Vaccine Therapy in Treating Patients With Malignant Glioma PHASE1 RATIONALE: Vaccines made from peptides and a person's dendritic cells may h...
Show More Location
Jonsson Comprehensive Cancer Center at UCLA
Learn More & Join Trial
Pembrolizumab and Autologous Dendritic Cells for the Treatment of Refractory Colorectal Cancer (CRC) PHASE2 The phase II trial tests whether pembrolizumab and dendritic cell-based tre...
Show More Location
Roswell Park Cancer Institute
Learn More & Join Trial
Melanoma Vaccine in Treating Patients With Stage III Melanoma After Surgery to Remove Lymph Nodes PHASE1 RATIONALE: Vaccines made from dendritic cells and tumor antigen peptides or...
Show More Location
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology - Warsaw
Learn More & Join Trial
Vaccination With Autologous Dendritic Cells Pulsed With HIV-Antigens for Treatment of Patients With Chronic HIV-Infection PHASE1 Phase I test of concept study: In an attempt to induce new immunity to HIV-...
Show More Learn More & Join Trial